SCHEMBL14043195

SCHEMBL14043195

Cc1cnn2c(NCCNC(=O)Nc3ccccc3-c3ccccc3)cc(-c3ccccc3O)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 2/20 0.41
▸ PDE10A Q9Y233 1/20 0.40
▸ GOT1 P17174 1/20 0.40
▸ NPC1 O15118 7/20 0.40
▸ RAB9A P51151 7/20 0.40
▸ KMT2A Q03164 7/20 0.40
▸ MEN1 O00255 6/20 0.40
▸ RET P07949 1/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ MAPK14 Q16539 1/20 0.39
▸ AHR P35869 1/20 0.39
▸ KDM4E B2RXH2 6/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ GSK3B P49841 3/20 0.39
▸ MAPT P10636 4/20 0.38
▸ HPGD P15428 3/20 0.38
▸ LMNA P02545 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ CLK1 P49759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12954520 0.89 GSK3B (0.43) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL14043342 0.87 MARS1 (0.40) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL14418659 0.85 MAPT (0.40) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL14418845 0.84 ALDH1A1 (0.43) NPC1RAB9AKMT2AMEN1AHR
SCHEMBL14613288 0.82 KMT2A (0.43) KMT2AMEN1SMN1; SMN2MAPTL3MBTL1
SCHEMBL14307169 0.82 ALDH1A1 (0.38) KMT2AMEN1KDM4ESMN1; SMN2GSK3B
SCHEMBL14050826 0.82 EPHX1 (0.46) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL13121929 0.80 CDK2 (0.58) GSK3B
SCHEMBL14607070 0.79 DRD2 (0.43) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL12954043 0.79 GSK3B (0.42) KDM4ESMN1; SMN2GSK3BHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130570-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
Send feedback